Defence Therapeutics (XCNQ:DTC) Ending Cash Position : C$0.35 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Ending Cash Position?

Defence Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was C$0.35 Mil.

Defence Therapeutics's quarterly Ending Cash Position declined from Mar. 2023 (C$2.88 Mil) to Sep. 2023 (C$1.35 Mil) and declined from Sep. 2023 (C$1.35 Mil) to Dec. 2023 (C$0.35 Mil).

Defence Therapeutics's annual Ending Cash Position increased from Jun. 2020 (C$1.87 Mil) to Jun. 2021 (C$5.45 Mil) but then declined from Jun. 2021 (C$5.45 Mil) to Jun. 2022 (C$0.51 Mil).

Defence Therapeutics Ending Cash Position Historical Data

The historical data trend for Defence Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Ending Cash Position Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Ending Cash Position

1.87

5.45

0.51

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial										0.13	0.16	2.88	1.35	0.35

Defence Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Defence Therapeutics's Ending Cash Position for the fiscal year that ended in Jun. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5.453	+	-4.946
	=	0.51

Defence Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.35	+	-0.999
	=	0.35

Defence Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director